Discontinuation report ODAN PROCTOMYXIN HC SUPPOSITORIES
Report ID | 143679 |
Drug Identification Number | 02242528 |
Brand name | ODAN PROCTOMYXIN HC SUPPOSITORIES |
Common or Proper name | Odan Proctomyxin suppositories |
Company Name | ODAN LABORATORIES LTD |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FRAMYCETIN SULFATE HYDROCORTISONE ESCULIN DIBUCAINE HYDROCHLORIDE |
Strength(s) | 10MG 5MG 10MG 5MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL RECTAL |
Packaging size | 12 |
ATC code | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-08-05 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | No remaining supply |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2021-08-06 | English | Compare |
v2 | 2021-08-05 | French | Compare |
v1 | 2021-08-05 | English | Compare |
Showing 1 to 3 of 3